Efficacy Evaluation of Three Endoscopic Therapies of Isolated Gastric Varices with Modified Tissue Adhesive

AI Zheng-lin, MIN Min, HU Ju-long, LIANG Xiu-xia, ZHOU Yu-ling, MA Jia-li, JIANG Yu, HE Ling-ling, LI Ping

Abstract

To evaluate the efficacy of three endoscopic therapies of isolated gastric varices (IGV) with modified tissue adhesive.   Methods   A retrospective analysis was conducted with the clinical data of 73 IGV patients who were treated between January 2008 and December 2019 at Beijing Ditan Hospital. Patient clinical data on age, sex, etiology, biochemistry findings, Child-Pugh classification, the type of spontaneous shunt, preoperative bleeding history, and the presence or absence of liver cancer were collected. The three therapies evaluated were endoscopic intravenous injection of tissue glue combined with lauromacrogol, endoscopic clip-assisted intravenous injection of tissue glue combined with lauromacrogol, and endoscopic clip and LOOP-assisted intravenous injection of tissue glue combined with lauromacrogol. Their respective clinical treatment outcomes, including ectopic embolism rate, survival rate, rebleeding rate, amount of lauromacrogol and tissue glue used, the number of endoscopic clips used, and the number of times of the procedure the patient underwent, were evaluated.   Results   In the patient baseline data, Child-Pugh grade, preoperative thrombus formation, and the presence or absence of liver cancer, showed significant difference between the three therapies (P<0.05). There was no significant difference in the rates of ectopic embolism among the three methods (P>0.05), but no ectopic embolism occurred after endoscopic clip-assisted intravenous injection of tissue glue combined with lauromacrogol, or after endoscopic clip and LOOP-assisted intravenous injection of tissue glue combined with lauromacrogol. There was no significant difference in the survival rate, the rebleeding rate, amount of lauromacrogol and tissue glue used for the three therapies, but there was significant difference in the number of endoscopic clips used and the number of times the procedure was conducted within one year (P<0.05).   Conclusion   The two endoscopic therapies of intravenous injection of modified tissue glue, one assisted by clip and the other assisted by clip and LOOP, can help reduce the number of procedures IGV patients undergo within one year.

 

Keywords: Isolated gastric varices, Endoscopic treatment, Intravenous injection of tissue glue combined with lauromacrogol, Clip, LOOP

 

Full Text:

PDF


References


TAYYEM O, BILAL M, SAMUEL R, et al. Evaluation and management of variceal bleeding. Dis Mon,2018,64(7): 312–320.

LESMANA C R A, RAHARJO M, GANI R A. Managing liver cirrhotic complications: Overview of esophageal and gastric varices. Clin Mol Hepatol,2020,26(4): 444–460.

DE F R. Portal hypertension Ⅶ. Proceedings of the Ⅶth Baveno consensus workshop: Personalized care in portal hypertension. New York, USA: Springer, 2022.

NORTHUP P C, GARCIA-PAGAN J C, GARCIA-TSAO G, et al. Vascular liver disorder, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American association for the study of liver disease. Hepatolgoy,2021,73(1): 366–413.

IBRAHIM M, MOSTAFA I, DEVIERE J. New developments in managing variceal bleeding. Gastroenterology,2018,154(7): 1964–1969.

JAKAB S S, GARCIA T G. Screening and surveillance of varices in patients with cirrhosis. Clin Gastroenterol Hepatol,2019,17(1): 26–29.

LUO X, XIANG T, WU J, et al. Endoscopic cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration for prevention of gastric variceal bleeding: A randomized controlled trial. Hepatology,2021,74(4): 2074–2084.

LESMANA C R A, KALISTA K F, SANDRA S, et al. Clinical significance of isolated gastric varices in liver cirrhotic patients: A single-referral-centre retrospective cohort study. JGH Open,2019,4(3): 511–518.

DE G A, RAUTOU P E, SCHOUTEN J, et al. Porto-sinusoidal vascular disease: Proposal and description of a novel entity. Lancet Gastroenterol Hepatol,2019,4(5): 399–411.

ALKHAZRAJI A, CURRY M P. The current knowledge about the therapeutic use of endoscopic sclerotherapy and endoscopic tissue adhesives in variceal bleeding. Expert Rev Gastroenterol Hepatol,2019, 13(9): 893–897.

IRISAWA A, SHIBUKAWA G, HOSHI K, et al. Endoscopic ultrasound-guided coil deployment with sclerotherapy for isolated gastric varices: Case series of feasibility, safety, and long-term follow-up. Dig Endosc,2020,32(7): 1100–1104.

LEE H A, CHANG J M, GOH H G, et al. Prognosis of patients with gastric variceal bleeding after endoscopic variceal obturation according to the type of varices. Eur J Gastroenterol Hepatol,2019,31(2): 211–217.

LI H, YE D, LI P, et al. Endoscopic clipping prior to GVO vs GVO in IGV1 bleeding: A multicenter retrospective clinical trial. Endosc Int Open,2019,7(11): E1365–E1370.

DE F R, BOSCH J, GARCIA-TSAO G, et al. Baveno Ⅶ-Renewing consensus in portal hypertension. J Hepatol,2022,76(4): 959–974.

AI Z L, LI P. Loop combined endoscopic clip and cyanoacrylate injection to treat severe gastric varices with spleno-renal shunt. VideoGIE,2020, 5(12): 652–654.

ALBAWARDY B, GOROSPE E C, SALEEM A, et al. Outcomes and predictors of rebleeding after 2-octyl cyanoacrylate injection in acute gastric variceal hemorrhage. J Clin Gastroenterol,2016,50(6): 458–463.

SINGH V, SINGH R, BHALLA A, et al. Cyanoacrylate therapy for the treatment of gastric varices a new method. J Dig Dis,2016,17(6): 392–398.

MANATAKA A, AUGOUSTAKI A, KOUROUMALIS E A, et al. Portal vein thrombosis in cirosis: Diagnosis, natural history, and therapeutic challenges. Ann Gastroenterol,2018,31(3): 315–329.

NI Z, CHEN H, TANG S, et al. The efficacy and the safety of prophylactic -butyl-2-cyanoacrylate injection for gastric varices using a modified injection technique. Surg Laparosc Endosc Percutan Tech, 2016, 26(4): e85−e90[2021-07-26]. https://journals.lww.com/surgical-laparoscopy/Fulltext/2016/08000/The_Efficacy_and_the_Safety_ of_Prophylactic.21.aspx. doi: 10.1097/SLE.0000000000000296.


Refbacks

  • There are currently no refbacks.